MW174A1 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
MW174A1
MW174A1 MW1/74*UA MW174A MW174A1 MW 174 A1 MW174 A1 MW 174A1 MW 174 A MW174 A MW 174A MW 174 A1 MW174 A1 MW 174A1
Authority
MW
MALAWI
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
MW1/74*UA
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MW174A1 publication Critical patent/MW174A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MW1/74*UA 1973-01-05 1974-01-04 Pharmaceutical formulation MW174A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB69073A GB1469521A (en) 1973-01-05 1973-01-05 Antimicrobial preparations

Publications (1)

Publication Number Publication Date
MW174A1 true MW174A1 (en) 1975-08-13

Family

ID=9708818

Family Applications (1)

Application Number Title Priority Date Filing Date
MW1/74*UA MW174A1 (en) 1973-01-05 1974-01-04 Pharmaceutical formulation

Country Status (31)

Country Link
JP (1) JPS5344531B2 (en)
AR (1) AR204521A1 (en)
AT (1) AT331986B (en)
AU (1) AU472758B2 (en)
BE (1) BE809378A (en)
CA (1) CA1014067A (en)
CH (4) CH616930A5 (en)
CS (1) CS212740B2 (en)
CY (1) CY1070A (en)
DD (2) DD111156A5 (en)
DE (1) DE2400218A1 (en)
DK (1) DK138006B (en)
ES (1) ES427078A1 (en)
FI (1) FI55296C (en)
FR (1) FR2213060B1 (en)
GB (1) GB1469521A (en)
HK (1) HK44280A (en)
HU (1) HU171200B (en)
IE (1) IE38713B1 (en)
IL (1) IL43954A (en)
IN (1) IN138511B (en)
IT (1) IT8047967A0 (en)
KE (1) KE3065A (en)
MW (1) MW174A1 (en)
MY (1) MY8100146A (en)
NL (1) NL183927C (en)
NO (1) NO140578C (en)
PH (1) PH12388A (en)
SE (1) SE430847B (en)
ZA (1) ZA7461B (en)
ZM (1) ZM20173A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1596044A (en) * 1977-04-14 1981-08-19 Wellcome Found Veterinary compositions
DE2731013C2 (en) * 1977-07-08 1982-07-15 Lentia Gmbh Process for the preparation of an aqueous solution for infusion
EP0007591B1 (en) 1978-08-01 1982-07-28 Ciba-Geigy Ag Stable medicinal solution on the basis of 2,6-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine(trimethoprim) and a sulphonamide, process for preparing and using it
HU180740B (en) * 1979-11-27 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing sulfonamide-containing,injectable pharmaceutical composition of prolongated activity
CH647412A5 (en) * 1980-03-25 1985-01-31 Hoffmann La Roche PHARMACEUTICAL PREPARATIONS.
HU212498B (en) * 1992-11-06 1996-07-29 Egyt Gyogyszervegyeszeti Gyar Process for producing water-soluble pharmaceutical compositions, containing sulfachlorpyridazin-sodium and trimethoprim
DE4331147A1 (en) 1993-09-14 1995-03-16 Nycomed Arzneimittel Gmbh Aqueous solution which can be administered intravenously
WO2018229659A1 (en) 2017-06-13 2018-12-20 3M Innovative Properties Company Modified polytetrafluoroethylene and aqueous dispersion containing the same
EP3527634A1 (en) 2018-02-15 2019-08-21 3M Innovative Properties Company Fluoropolymers and fluoropolymer dispersions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1028204A (en) * 1963-06-28 1966-05-04 May & Baker Ltd Veterinary coccidiostatic compositions
BR6915082D0 (en) * 1969-05-16 1973-03-08 Wellcome Found PROCESS OF PREPARATION OF BENZYL-PYRIMIDINES
RO67383A (en) * 1970-10-22 1981-07-30 The Wellcome Foundation Ltd,Gb PROCESS FOR THE PREPARATION OF 2,4-DIAMINO-5-BENZYLPIRIMIDINE
GB1407971A (en) * 1971-04-16 1975-10-01 Wellcome Found 2,4-diamino -4-3,4,5-triethoxybenzyl pyrimidine and methods of preparation therefor
BE787236A (en) * 1971-08-05 1973-02-05 Wellcome Found POTENTIALIZATION COMPOSITIONS

Also Published As

Publication number Publication date
CS212740B2 (en) 1982-03-26
CH616931A5 (en) 1980-04-30
SE430847B (en) 1983-12-19
GB1469521A (en) 1977-04-06
JPS49100215A (en) 1974-09-21
FR2213060B1 (en) 1976-09-03
IT8047967A0 (en) 1980-02-21
NL183927C (en) 1989-03-01
HU171200B (en) 1977-11-28
AU472758B2 (en) 1976-06-03
FI55296B (en) 1979-03-30
NL183927B (en) 1988-10-03
AT331986B (en) 1976-09-10
FI55296C (en) 1979-07-10
FR2213060A1 (en) 1974-08-02
MY8100146A (en) 1981-12-31
IL43954A0 (en) 1974-05-16
CA1014067A (en) 1977-07-19
DK138006B (en) 1978-06-26
NO140578B (en) 1979-06-25
IL43954A (en) 1977-05-31
CH616932A5 (en) 1980-04-30
IE38713L (en) 1975-07-03
IN138511B (en) 1976-02-14
AU6413674A (en) 1975-07-03
KE3065A (en) 1980-07-25
ATA2274A (en) 1975-12-15
BE809378A (en) 1974-07-03
CH628335A5 (en) 1982-02-26
PH12388A (en) 1979-01-29
DD111156A5 (en) 1975-02-05
ES427078A1 (en) 1976-07-16
NL7400094A (en) 1974-07-09
AR204521A1 (en) 1976-02-12
CH616930A5 (en) 1980-04-30
CY1070A (en) 1980-10-24
IE38713B1 (en) 1978-05-24
HK44280A (en) 1980-08-22
DK138006C (en) 1979-01-08
JPS5344531B2 (en) 1978-11-29
DD115120A5 (en) 1975-09-12
DE2400218A1 (en) 1974-07-18
NO740022L (en) 1974-07-08
NO140578C (en) 1979-10-03
ZM20173A1 (en) 1974-09-23
ZA7461B (en) 1975-08-27

Similar Documents

Publication Publication Date Title
ZA743934B (en) Pharmaceutical compositions
AU7259274A (en) Medicaments
ZA731808B (en) Pharmaceutical compositions
HK72578A (en) Pharmaceutical compositions
IL44646A0 (en) Novel pharmaceutical tablets
ZA744373B (en) Pharmaceutical compositions
AU7201374A (en) Pharmaceutical compositions
ZM20173A1 (en) Pharmaceutical formulation
ZA742956B (en) Pharmaceutical compositions containing triazolo-isoquinoline derivatives
ZA744488B (en) Pharmaceutical compositions
ZA745756B (en) Pharmaceutical compositions
ZA742064B (en) Pharmaceutical compositions
ZA747276B (en) Pharmaceutical compositions
KE2808A (en) Tablet formulation
ZA746271B (en) Pharmaceutical compositions
AU7349374A (en) Medicinal composition
ZA731012B (en) Pharmaceutical compositions
HK57578A (en) Pharmaceutical compositions
ZA743282B (en) Novel hormonic formulation
AU7194974A (en) Pharmaceutical product
ZA741050B (en) Pharmaceutical compositions
NZ175566A (en) Decapetides and pharmaceutical compositions
ZA734331B (en) Pharmaceutical compositions
HK53780A (en) Pharmaceutical preparations
AU7274074A (en) Drug